Svenja Rühland

441 citations
5 papers · 317 indexed · h-index 4

Svenja Rühland

5 papers receiving 300 citations

Peers

Svenja Rühland
Comparison fields: 5 of 42
  • Oncology 164
  • Pulmonary and Respiratory Medicine 128
  • Immunology 82
  • Radiology, Nuclear Medicine and Imaging 75
  • Epidemiology 98
Replace Tetsuro Urashima with:
Tetsuro Urashima Japan
Eric Klein United States
Ryohei Nishino Japan
Gregor Manukian United States
Redas Trepiakas Denmark
Jean‐Baptiste Gorin France
Ulf Forssmann Germany
Zi-Ming Zhao United States
Tatiana Seregina United States
Anusha Muralidhar United States
Svenja Rühland relative to Tetsuro Urashima Japan Tetsuro Urashima's profile →
Citations per field
00.5×3.1×
Tetsuro Urashima · 1×
Citations per year

Countries citing papers authored by Svenja Rühland

Since Specialization
Citations

This map shows the geographic impact of Svenja Rühland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Svenja Rühland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Svenja Rühland more than expected).

Fields of papers citing papers by Svenja Rühland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Svenja Rühland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Svenja Rühland. The network helps show where Svenja Rühland may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Svenja Rühland, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Svenja Rühland Line = papers co-authored together Svenja Rühland links everyone, so they are left out of the graph.

All Works

5 of 5 papers shown
#Work
1 201733
2 201535
3 2004155
4 199793
5 19901

About Svenja Rühland

Svenja Rühland is a scholar working on Oncology, Immunology, Cancer Research, Pediatrics, Perinatology and Child Health and Genetics, having authored 5 papers that have together received 317 indexed citations. Recurring topics across this work include CAR-T cell therapy research (2 papers), Assisted Reproductive Technology and Twin Pregnancy (1 paper), Neonatal and fetal brain pathology (1 paper), Virus-based gene therapy research (1 paper), Fibroblast Growth Factor Research (1 paper), Neuroendocrine Tumor Research Advances (1 paper), Cancer Immunotherapy and Biomarkers (1 paper) and Immune Cell Function and Interaction (1 paper). The work is most often cited by research in Oncology (164 citations), Pulmonary and Respiratory Medicine (128 citations), Immunology (82 citations), Radiology, Nuclear Medicine and Imaging (75 citations) and Epidemiology (98 citations). Svenja Rühland has collaborated with scholars based in Germany and Switzerland. Frequent co-authors include Ewald Moser, Egbert Nitzsche, W. Digel, Ingo Brink, Michael Mix, Michael Henke, Nadir Ghanem, Erich Stoelben, T. Ahlert and G. Bastert. Their work appears in journals such as Journal of Clinical Oncology, Endocrine Related Cancer, Cancer Research, European Journal of Nuclear Medicine and Molecular Imaging and Geburtshilfe und Frauenheilkunde.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026